FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis
- PMID: 25140952
- DOI: 10.1056/NEJMp1314385
FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis
Comment on
-
Multidrug-resistant tuberculosis and culture conversion with bedaquiline.N Engl J Med. 2014 Aug 21;371(8):723-32. doi: 10.1056/NEJMoa1313865. N Engl J Med. 2014. PMID: 25140958 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources